Worldwide Clinical Trials announced Sherilyn Adcock, RPH, PHD, has been promoted to chief scientific officer, Early Phase Development.
In her new role, Dr. Adcock will provide key insight to our clinical development teams and to sponsors as they navigate the complexities of early phase drug development.
With a background in pharmacy and clinical operations, Dr. Adcock has dedicated her career to early phase development. Based in Austin, Texas, she has played a role in Worldwide’s growth since joining as director of clinical research in 2001. Dr. Adcock has been involved in expanding the Early Phase business to an integrated flexible, fit for service, clinical pharmacology unit, pharmacy compounding services, specialty pharmacy services, and full bioanalysis laboratory.
“For the last 20 years, Sherilyn has forged a reputation for always keeping our customers’ needs front and center,” said Mike Mencer, executive vice president, Early Phase Drug Development, Worldwide Clinical Trials. “I am confident that her strong scientific acumen and deep drug discovery experience will bring an invaluable perspective in driving the next phase of our trajectory.”
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!
Before joining Worldwide, Dr. Adcock served in executive clinical research roles for SCIREX Corporation and Biomedical Research Group (now Premier Research), Phoenix International Life Sciences (now Celerion), HealthQuest Therapy and Research Institute and Pharmaco International (now PPD).
Prior to entering clinical research, she spent several years working in hospital and clinical settings as a pharmacist and in development and oversight of specialty pharmacy services.
“I am privileged to work alongside the best of the best at Worldwide as we continue to give our all to the high-stakes, exciting field of early phase drug development,” Dr. Adcock said. “And, I’m proud of the value our medical and scientific focus brings to sponsors who are looking for a clinical partner willing to help guide them through the process. This combination will propel the next phase of Worldwide’s exceptional growth, and I am thrilled to be a part of it.”
Dr. Adcock earned her B.S. in pharmacy, a M.S. in health science, and a Ph.D. in community health and biostatistics, all from the University of Texas. She is licensed by the Texas State Board of Pharmacy and holds certifications in sterile product preparation, immunization, and pharmacogenomics.